NCT02815774View on ClinicalTrials.gov

SP2086 Pharmacokinetic Study in Renal Insufficiency Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Renal Insufficiency
Interventions
DRUG

SP2086

all subjects were given SP2086 50mg only one time.

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02815774 - SP2086 Pharmacokinetic Study in Renal Insufficiency Patients | Biotech Hunter | Biotech Hunter